visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Sonnet Biotherapeutics, Inc.

    Get Full Access

    Description

    • Sonnet BioTherapeutics is an early stage company developing a pipeline of bifunctional therapies that attack immune-modulating targets to control cancer cells. Sonnet BioTherapeutics is utilizing a platform approach to develop a library of cancer-fighting immunotherapies. Sonnet is based in Cranbury, New Jersey. Sonnet Mission: Sonnet BioTherapeutics is a platform enabled proof-of-concept engine created to generate immuno-oncology candidates and develop them into Phase II assets. We are leveraging a unique IP driven platform: Single Chain Platform with PK enhancement Selectively targeting tumors and their micro-environment Validated targets only Dual targeting can create synergies
    • location

      Headquarters:1 Duncan Dr Ste 4 , Cranbury, New Jersey, United States

      More
    • Sonnet Biotherapeutics, Inc. phone

      Phone Number: +1 609-664-2195

    • Sonnet Biotherapeutics, Inc. website

      Website: https://www.sonnetbio.com

    • Sonnet Biotherapeutics, Inc. employees

      Employees:10

    • Sonnet Biotherapeutics, Inc. revenue

      Revenue:$10 - 50M

    • Sonnet Biotherapeutics, Inc. legal name

      Legal Name:Sonnet Biotherapeutics, Inc.

    • Sonnet Biotherapeutics, Inc.'s Social Media

      Sonnet Biotherapeutics, Inc. linkedin
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    Chief Scientific Officer And Co-Founder for Sonnet Biotherapeutics, Inc.

    John Cini

    Chief Scientific Officer And Co-Founder

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    John Cini

    Chief Scientific Officer And Co-Founder

    Stephen Mcandrew

    Vice President, Business Development

    Manuel Dafonseca

    Vice President Clinical Operations

    Frequently Asked Questions regarding Sonnet Biotherapeutics, Inc.

    • Where are Sonnet Biotherapeutics, Inc.'s Headquarters?

      Sonnet Biotherapeutics, Inc.'s Headquarters are in 1 Duncan Dr Ste 4 ,Cranbury,New Jersey,United States

    • What is Sonnet Biotherapeutics, Inc.'s phone number?

      Sonnet Biotherapeutics, Inc.'s phone number is +1 609-664-2195

    • What is Sonnet Biotherapeutics, Inc.'s official website?

      Sonnet Biotherapeutics, Inc.'s official website is https://www.sonnetbio.com

    • What is Sonnet Biotherapeutics, Inc.'s Revenue?

      Sonnet Biotherapeutics, Inc.'s revenue is $10 - 50M

    • What is Sonnet Biotherapeutics, Inc.'s NAICS code?

      Sonnet Biotherapeutics, Inc.'s NAICS code is 541713

    • How many employees are working in Sonnet Biotherapeutics, Inc.

      Sonnet Biotherapeutics, Inc. has 10 employees

    • What is Sonnet Biotherapeutics, Inc.'s Industry?

      Sonnet Biotherapeutics, Inc. is in the industry of Biotechnology

    • Who is Sonnet Biotherapeutics, Inc.'s Chief Scientific Officer And Co-Founder?

      Sonnet Biotherapeutics, Inc.'s Chief Scientific Officer And Co-Founder is John Cini

    Company Directory